Compare TAL & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TAL | BLCO |
|---|---|---|
| Founded | 2003 | 1853 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Ophthalmic Goods |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 6.0B |
| IPO Year | 2010 | 2022 |
| Metric | TAL | BLCO |
|---|---|---|
| Price | $11.02 | $17.46 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 12 |
| Target Price | $11.15 | ★ $18.55 |
| AVG Volume (30 Days) | ★ 3.5M | 438.6K |
| Earning Date | 01-01-0001 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,101,000,000.00 |
| Revenue This Year | $34.12 | $8.61 |
| Revenue Next Year | $22.50 | $5.52 |
| P/E Ratio | $23.36 | ★ N/A |
| Revenue Growth | N/A | ★ 6.47 |
| 52 Week Low | $8.50 | $10.45 |
| 52 Week High | $14.66 | $18.92 |
| Indicator | TAL | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 49.44 | 48.74 |
| Support Level | $10.67 | $16.35 |
| Resistance Level | $11.14 | $17.66 |
| Average True Range (ATR) | 0.33 | 0.49 |
| MACD | 0.02 | -0.12 |
| Stochastic Oscillator | 82.65 | 31.12 |
TAL Education Group is a smart learning solutions provider in China. It operates a few business lines including enrichment learning, high school academic tutoring, learning technology, and content solutions. Among those business lines, TAL focuses on enrichment learning and content solutions.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.